e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 27

Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results

Meghan A. Baker; Bethany Baer; Martin Kulldorff; Lauren Zichittella; Rebecca Reindel; Sandra DeLuccia; Hana Lipowicz; Katherine E. Freitas · 2019 · PLoS Medicine

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Kawasaki disease is an acute vasculitis that primarily affects children younger than 5 years of age. Its etiology is unknown. The United States Vaccine Safety Datalink conducted postlicensure safety surveillance for 13-valent pneumococcal conjugate vaccine (PCV13), comparing the risk of Kawasaki disease within 28 days of PCV13 vaccination with the historical risk after 7-valent PCV (PCV7) vaccination and using chart-validation. A relative risk (RR) of 2.38 (95% CI 0.92-6.38) was found. Concurrently, the Food and Drug Administration (FDA) conducted a postlicensure safety review that

Abstract by Meghan A. Baker; Bethany Baer; Martin Kulldorff; Lauren Zichittella; Rebecca Reindel; Sandra DeLuccia; Hana Lipowicz; Katherine E. Freitas, PLoS Medicine (2019) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1371/journal.pmed.1002844